ImmuneAGE Bio Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Out of Business

  • Employees
  • 7

Employees

  • Latest Deal Type
  • Out of Business

ImmuneAGE Bio General Information

Description

Developer of a drug rejuvenation platform designed to address the root cause of aging of the immune system. The company's platform allows drug screening at scale to identify small molecules and biologics that rejuvenate HSCs and other immune cell types, and also focuses on the immune system through an orally available small molecule that enhances mitochondrial function, with efficacy in models of infection, oncology, and metabolism, enabling patients to cure aging problems with their drug screening.

Contact Information

Website
www.immuneage.bio
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • Lausanne
  • Switzerland
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • Lausanne
  • Switzerland

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ImmuneAGE Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Out of Business 09-Jun-2026 Completed Out of Business
3. Early Stage VC 21-Mar-2024 Completed Pre-Clinical Trials
2. Early Stage VC 12-Jul-2024 $2M $2M Completed Pre-Clinical Trials
1. Early Stage VC 10-May-2023 Completed Pre-Clinical Trials
To view ImmuneAGE Bio’s complete valuation and funding history, request access »

ImmuneAGE Bio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ready to get started?

Request a free trial

ImmuneAGE Bio FAQs

  • When was ImmuneAGE Bio founded?

    ImmuneAGE Bio was founded in 2021.

  • Where is ImmuneAGE Bio headquartered?

    ImmuneAGE Bio is headquartered in Lausanne, Switzerland.

  • What is the size of ImmuneAGE Bio?

    ImmuneAGE Bio has 7 total employees.

  • What industry is ImmuneAGE Bio in?

    ImmuneAGE Bio’s primary industry is Drug Discovery.

  • Is ImmuneAGE Bio a private or public company?

    ImmuneAGE Bio is a Private company.

  • What is ImmuneAGE Bio’s current revenue?

    The current revenue for ImmuneAGE Bio is .

  • How much funding has ImmuneAGE Bio raised over time?

    ImmuneAGE Bio has raised $12M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process